BackKala Bio Overview

Kala Bio EBIT

EBIT (Earnings Before Interest and Taxes) analysis for KALA.

Quarterly EBIT

-$1.80M
83.11% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$34.06M
8.13% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)